CoChat

Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Studies from this laboratory have shown that obese men have elevated serum estrogen levels and diminished levels of follicle-stimulating hormone (FSH) and free and total testosterone, all in proportion to their degree of obesity. The decreases in testosterone and FSH constitute a state of hypogonadotropic hypogonadism (HHG), and we have hypothesized that it results from feedback suppression of the pituitary by the elevated estrogen levels. We tested this hypothesis by lowering the serum estrogens of 6 health obese men (body mass index [BMI], 38 to 73) by administering the aromatase inhibitor testolactone (1 g daily for 6 weeks). Twenty-four-hour mean serum testosterone rose in every subject, from a mean of 290 +/- 165 ng/dL to a mean of 403 +/- 170 (P <.0003); 24-hour mean serum estradiol decreased in every subject, from a mean of 40 +/- 10.8 pg/mL to a mean of 29 +/- 6.7 (P <.004); and 24-hour mean serum luteinizing hormone (LH) increased in every subject, from a mean of 14.3 +/- 4.1 mIU/mL to a mean of 19.3 +/- 5.1 (P <.004). The rise in mean LH was due to an increase in the amplitude of the individual secretory pulses, especially at night. Twenty-four-hour mean serum estrone decreased nonsignificantly, from 48 +/- 14 pg/mL to 39 +/- 6.4, and 24-hour mean serum FSH increased nonsignificantly, from 13.5 +/- 5.3 mIU/mL to 15.0 +/- 5.4. The results are in accordance with the hypothesis, in that inhibition of estrogen biosynthesis (through administration of the aromatase inhibi…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0026-0495(03)00186-0

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 10 references

Cited by

See all 123

Metadata

Authors
Zumoff, B., Miller, L. K., & Strain, G. W.
Affiliations
Mount Sinai Beth Israel (US)
Venue
Metabolism
Publisher
Elsevier BV
Published
2003-09
Volume
52
Issue
9
Pages
1126-1128
ISSN
0026-0495 (ISSN-L)
OpenAlex
W2157023352
Cited by
118
References
10
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 4 · 2015: 5 · 2014: 12 · 2013: 5 · 2012: 13
FWCI
2.03
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
hypogonadotropic hypogonadism, obesity, testolactone, aromatase inhibitors, testosterone, luteinizing hormone, follicle-stimulating hormone, estradiol, estrone, hypothalamic-pituitary-gonadal axis, male hypogonadism
MeSH terms
Adult, Enzyme Inhibitors, Estradiol, Estrogens, Estrone, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Obesity, Testolactone, Testosterone, Body Mass Index, Aromatase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. https://app.cochat.ai/papers/10.1016/s0026-0495(03)00186-0
The paper
Zumoff, B., Miller, L. K., & Strain, G. W. (2003). Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism. https://doi.org/10.1016/s0026-0495(03)00186-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.